Ann Arbor Biosciences To Sell New COVID-19 Test – Up To 1M A Day
ANN ARBOR—Officials of Swift Biosciences, a developer of gene sequencing technology, and BillionToOne, a Menlo Park, Calif. diagnostics company, announced that Swift Bioscience will be the exclusive distributor of BillionToOne’s RNA extraction-free, Emergency Use Authorization (EUA) COVID-19 Test Kit for high capacity testing of up to a million tests per day. The test is designed to detect




